Abstract:Backgroundβ-carotene is a carotenoid compound that has been widely used not only in the industrial production of pharmaceuticals but also as nutraceuticals, animal feed additives, functional cosmetics, and food colorants. Currently, more than 90% of commercial β-carotene is produced by chemical synthesis. Due to the growing public concern over food safety, the use of chemically synthesized β-carotene as food additives or functional cosmetic agents has been severely controlled in recent years. This has reignited the enthusiasm for seeking natural β-carotene in large-scale fermentative production by microorganisms.ResultsTo increase β-carotene production by improving the isopentenyl pyrophosphate (IPP) and geranyl diphospate (GPP) concentration in the cell, the optimized MEP (methylerythritol 4-phosphate) pathway containing 1-deoxy-D-xylulose-5-phosphate synthase (DXS) and isopentenyl pyrophosphate isomerase (FNI) from Bacillus subtilis, geranyl diphosphate synthase (GPPS2) from Abies grandis have been co-expressed in an engineered E. coli strain. To further enhance the production of β-carotene, the hybrid MVA (mevalonate) pathway has been introduced into an engineered E. coli strain, co-expressed with the optimized MEP pathway and GPPS2. The final genetically modified strain, YJM49, can accumulate 122.4±6.2 mg/L β-carotene in flask culture, approximately 113-fold and 1.7 times greater than strain YJM39, which carries the native MEP pathway, and YJM45, which harbors the MVA pathway and the native MEP pathway, respectively. Subsequently, the fermentation process was optimized to enhance β-carotene production with a maximum titer of 256.8±10.4 mg/L. Finally, the fed-batch fermentation of β-carotene was evaluated using the optimized culture conditions. After induction for 56 h, the final engineered strain YJM49 accumulated 3.2 g/L β-carotene with a volumetric productivity of 0.37 mg/(L · h · OD600) in aerobic fed-batch fermentation, and the conversion efficiency of glycerol to β-carotene (gram to gram) reached 2.76%.ConclusionsIn this paper, by using metabolic engineering techniques, the more efficient biosynthetic pathway of β-carotene was successfully assembled in E. coli BL21(DE3) with the optimized MEP (methylerythritol 4-phosphate) pathway, the gene for GPPS2 from Abies grandis, the hybrid MVA (mevalonate) pathway and β-carotene synthesis genes from Erwinia herbicola.

Construction Of A Controllable Beta-Carotene Biosynthetic Pathway By Decentralized Assembly Strategy In Saccharomyces Cerevisiae

Construction of a Highly Efficient Synthetic Lycopene Engineered Saccharomyces Cerevisiae

Sequential control of biosynthetic pathways for balanced utilization of metabolic intermediates in Saccharomyces cerevisiae.

Heterologous biosynthesis of lutein in S. cerevisiae enabled by temporospatial pathway control

Switching Carbon Metabolic Flux for Enhancing the Production of Sesquiterpene-Based High-Density Biofuel Precursor in Saccharomyces Cerevisiae

Assembly of Biosynthetic Pathways in Saccharomyces Cerevisiae Using a Marker Recyclable Integrative Plasmid Toolbox

Construction of Canthaxanthin-Producing Yeast by Combining Spatiotemporal Regulation and Pleiotropic Drug Resistance Engineering

Construction of Lycopene-Overproducing Saccharomyces Cerevisiae by Combining Directed Evolution and Metabolic Engineering.

Enhanced Astaxanthin Production in S. Cerevisiae by Combinatorial Engineering of Gene Targets Outside the Synthetic Pathway

Combinatorial Optimization of MEP Pathway to Improve β-Carotene Yield

Engineering a growth-phase-dependent biosynthetic pathway for carotenoid production in Saccharomyces cerevisiae

Alleviation of metabolic bottleneck by combinatorial engineering enhanced astaxanthin synthesis in Saccharomyces cerevisiae.

Production of β-carotene in Saccharomyces cerevisiae through altering yeast lipid metabolism

Construction of engineering Saccharomyces cerevisiae producing β-carotene

Pathway engineering of Saccharomyces cerevisiae for efficient lycopene production

Retargeting of heterologous enzymes results in improved β-carotene synthesis in Saccharomyces cerevisiae

Metabolic engineering of Saccharomyces cerevisiae for enhanced production of caffeic acid

Biosynthesis of β-carotene in engineered E. coli using the MEP and MVA pathways

Constructing Yeast Chimeric Pathways to Boost Lipophilic Terpene Synthesis.

Enhanced Production of Β-Carotene in Recombinant Saccharomyces Cerevisiae by Inverse Metabolic Engineering with Supplementation of Unsaturated Fatty Acids

Dual regulation of lipid droplet-triacylglycerol metabolism and ERG9 expression for improved β-carotene production in Saccharomyces cerevisiae